相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Immunologic and Virologic Events in Early HIV Infection Predict Subsequent Rate of Progression
Anuradha Ganesan et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
The macrophage: the intersection between HIV infection and atherosclerosis
Suzanne M. Crowe et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Proteinuria, Creatinine Clearance, and Immune Activation in Antiretroviral-Naive HIV-Infected Subjects
Samir K. Gupta et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Activation and Coagulation Biomarkers Are Independent Predictors of the Development of Opportunistic Disease in Patients with HIV Infection
Alison J. Rodger et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG
Akinyemi I. Ojesina et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
The effect of HMG-CoA reductase inhibitors on naturally occurring CD4(+)CD25(+) T cells
Karin Mausner-Fainberg et al.
ATHEROSCLEROSIS (2008)
Relationship between T cell activation and CD4(+) T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Failure of atorvastatin to modulate CSFHIV-1 infection - Results of a pilot study
J. C. Probasco et al.
NEUROLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy
Jeffrey A. Johnson et al.
PLOS MEDICINE (2008)
Intravenous immunoglobulin (IVIG) treatment for modulation of immune activation in human immunodeficiency virus type 1 infected therapy-naive individuals
Joost N. Vermeulen et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2007)
Class of antiretroviral drugs and the risk of myocardial infarction
Nina Friis-Moller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Atoirvastatin - Pharmacological characteristics and lipid-lowering effects
Andrea Poli
DRUGS (2007)
Cyclosporin a provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy: Results of a randomized, controlled trial of the AIDS clinical trials group A5138
Michael M. Lederman et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Siravastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo
Alexander Niessner et al.
ATHEROSCLEROSIS (2006)
Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome
Andreas Link et al.
EUROPEAN HEART JOURNAL (2006)
Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma -: pharmacokinetic study
V. Borek-Dohalsky et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2006)
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
J Greenwood et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms
MK Jain et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes
KK Ray et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Pravastatin does not have a consistent antiviral effect in chronically HIV-infected individuals on antiretroviral therapy
PA Sklar et al.
AIDS (2005)
Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes
H Methe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Statins could be used to control replication of some viruses, including HIV-1
C Gilbert et al.
VIRAL IMMUNOLOGY (2005)
Statins inhibit HIV-1 infection by down-regulating Rho activity
G del Real et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Inflammation, immunity, and HMG-CoA reductase inhibitors -: Statins as antiinflammatory agents?
U Schönbeck et al.
CIRCULATION (2004)
Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1
JF Giguère et al.
JOURNAL OF VIROLOGY (2004)
Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells
F Mulhaupt et al.
CARDIOVASCULAR RESEARCH (2003)
T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy
PW Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Lymphocyte function-associated antigen-1 blockade by statins: Molecular basis and biological relevance
G Weitz-Schmidt
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2003)
Plasma membrane rafts play a critical role in HIV-1 assembly and release
A Ono et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products
L Diomede et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
HMG-CoA reductase inhibitor modulates monocyte-endothelial cell interaction under physiological flow conditions in vitro - Involvement of Rho GTPase-dependent mechanism
M Yoshida et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site
G Weitz-Schmidt et al.
NATURE MEDICINE (2001)
Statins as a newly recognized type of immunomodulator
B Kwak et al.
NATURE MEDICINE (2000)
分享论文
